封面
市场调查报告书
商品编码
1540817

2024-2032 年按产品和服务、技术(聚合酶链反应、毛细管电泳、微阵列、定序、质谱等)、应用、最终用户和地区分類的基因分型市场报告

Genotyping Market Report by Product and Service, Technology (Polymerase Chain Reaction, Capillary Electrophoresis, Microarray, Sequencing, Mass Spectrometry, and Others), Application, End User, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球基因分型市场规模达194亿美元。

基因分型是指检查 DNA 序列以确定生物体(包括人类、植物、动物和微生物)基因型的遗传组成的分析程序。基因测试使科学家能够透过生物测定检测遗传差异来检查各种遗传偏差,例如 DNA 结构的变化和单核苷酸多态性。透过使用这些信息,可以比较个体之间的差异,同时提供与个体遗传史相关的资料。另一方面,病毒和细菌等微生物的基因分型有助于透过找出病毒和细菌疾病的来源来防止病原体的传播。

基因分型市场趋势:

全球市场的主要推动力是全球医疗机构对基于基因型的诊断测试的需求不断增长。这可以归因于慢性疾病的日益流行,包括癌症和遗传性疾病。除此之外,药物发现和开发过程中资料分析和药物基因组学中生物资讯解决方案的日益采用也为市场成长提供了动力。专注于基因组药物开发和精准医学研究的研发(R&D)活动投资大幅增加进一步推动了市场。除此之外,全球基因分型测试数量的增加对试剂的需求不断增加,正在为市场创造积极的前景。促进市场成长的其他一些因素包括容易患多种疾病的老年人口不断增加、基因分型产品的持续技术进步、大众对个人化药物的认识不断增强以及医疗保健的大幅扩展支出。

本报告回答的关键问题:

  • 迄今为止,全球基因分型市场的表现如何,未来几年将如何表现?
  • COVID-19 对全球基因分型市场有何影响?
  • 主要区域市场有哪些?
  • 基于产品和服务的市场区隔是什么?
  • 基于技术的市场区隔是什么?
  • 基于应用程式的市场区隔是什么?
  • 基于最终用户的市场区隔是什么?
  • 产业价值链的各个阶段是什么?
  • 该行业的关键驱动因素和挑战是什么?
  • 全球基因分型市场的结构如何?
  • 产业竞争程度如何?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球基因分型市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章:市场区隔:依产品与服务

  • 仪器仪表
    • 市场趋势
    • 市场预测
  • 试剂和试剂盒
    • 市场趋势
    • 市场预测
  • 软体和服务
    • 市场趋势
    • 市场预测

第 7 章:市场区隔:依技术

  • 聚合酶炼式反应 (PCR)
    • 市场趋势
    • 市场预测
  • 毛细管电泳
    • 市场趋势
    • 市场预测
  • 微阵列
    • 市场趋势
    • 市场预测
  • 定序
    • 市场趋势
    • 市场预测
  • 质谱分析
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章:市场区隔:按应用

  • 药物基因组学
    • 市场趋势
    • 市场预测
  • 诊断及个人化医疗
    • 市场趋势
    • 市场预测
  • 农业生物技术
    • 市场趋势
    • 市场预测
  • 动物遗传学
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章:市场区隔:按最终用户

  • 製药和生物製药公司
    • 市场趋势
    • 市场预测
  • 诊断与研究实验室
    • 市场趋势
    • 市场预测
  • 学术机构
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章:市场区隔:按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分:按国家/地区
    • 市场预测

第 11 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章:价值链分析

第 13 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章:价格分析

第15章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Qiagen NV
    • Standard BioTools Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5815

The global genotyping market size reached US$ 19.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.4 Billion by 2032, exhibiting a growth rate (CAGR) of 12.5% during 2024-2032.

Genotyping refers to an analytical procedure that examines DNA sequences to determine the genetic constitution in the genotypes of living organisms, including humans, plants, animals, and microorganisms. Genetic tests enable scientists to examine a variety of genetic deviations, such as changes in DNA structure and single nucleotide polymorphisms, by detecting genetic differences through biological assays. By using this information, the differences between individuals can be compared while providing data related to the genetic history of an individual. Genotyping of microorganisms, such as viruses and bacteria, on the other hand, helps prevent the spread of pathogens by pinpointing the source of viral and bacterial diseases.

Genotyping Market Trends:

The global market is majorly driven by the rising demand for genotypic-based diagnostic testing in healthcare facilities across the globe. This can be attributed to the increasing prevalence of chronic diseases, including cancer and genetic disorders. In addition to this, the rising adoption of bioinformatics solutions in data analysis and pharmacogenomics in the drug discovery and development processes is also providing an impetus to the market growth. The market is further driven by the substantial rise in investments in research and development (R&D) activities focusing on genomic drug development and precision medicine research. Apart from this, the escalating demand for reagents for the augmenting volumes of genotyping tests on the global level is creating a positive outlook for the market. Some of the other factors that are contributing to the growth of the market include the rising geriatric population that is susceptible to developing numerous medical conditions, continual technological advancements in genotyping products, the growing awareness regarding personalized medicines among the masses and a considerable expansion of healthcare expenditure.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global genotyping market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and service, technology, application and end user.

Breakup by Product and Service:

Instruments

Reagents and Kits

Software and Services

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Capillary Electrophoresis

Microarray

Sequencing

Mass Spectrometry

Others

Breakup by Application:

Pharmacogenomics

Diagnostics and Personalized Medicine

Agricultural Biotechnology

Animal Genetics

Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Diagnostics and Research Laboratories

Academic Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Qiagen N.V, Standard BioTools Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global genotyping market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global genotyping market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product and service?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global genotyping market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genotyping Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Kits
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Capillary Electrophoresis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microarray
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Sequencing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Mass Spectrometry
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pharmacogenomics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostics and Personalized Medicine
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Agricultural Biotechnology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Animal Genetics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biopharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostics and Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bio-Rad Laboratories Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Danaher Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Eurofins Scientific SE
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 F. Hoffmann-La Roche AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Illumina Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Laboratory Corporation of America Holdings
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Qiagen N.V
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Standard BioTools Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genotyping Market: Major Drivers and Challenges
  • Figure 2: Global: Genotyping Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Genotyping Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Genotyping Market: Breakup by Product and Service (in %), 2023
  • Figure 5: Global: Genotyping Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Genotyping Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Genotyping Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Genotyping Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Genotyping (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Genotyping (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Genotyping (Reagents and Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Genotyping (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Genotyping (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Genotyping (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Genotyping (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Genotyping (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Genotyping (Capillary Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Genotyping (Capillary Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Genotyping (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Genotyping (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Genotyping (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Genotyping (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Genotyping (Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Genotyping (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Genotyping (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Genotyping (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Genotyping (Pharmacogenomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Genotyping (Pharmacogenomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Genotyping (Diagnostics and Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Genotyping (Diagnostics and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Genotyping (Animal Genetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Genotyping (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Genotyping (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Genotyping (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Genotyping (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Genotyping (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Genotyping (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Genotyping (Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Genotyping (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Genotyping (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Genotyping (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: North America: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: North America: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United States: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United States: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Canada: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Canada: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Asia-Pacific: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Asia-Pacific: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: China: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: China: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Japan: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Japan: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: India: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: India: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: South Korea: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: South Korea: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Australia: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Australia: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Indonesia: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Indonesia: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Europe: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Europe: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Germany: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Germany: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: France: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: France: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: United Kingdom: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: United Kingdom: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Italy: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Italy: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Spain: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Spain: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Russia: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Russia: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Latin America: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Latin America: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Brazil: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Brazil: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Mexico: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Mexico: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Middle East and Africa: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Middle East and Africa: Genotyping Market: Breakup by Country (in %), 2023
  • Figure 93: Middle East and Africa: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Global: Genotyping Industry: SWOT Analysis
  • Figure 95: Global: Genotyping Industry: Value Chain Analysis
  • Figure 96: Global: Genotyping Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genotyping Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Genotyping Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
  • Table 3: Global: Genotyping Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Genotyping Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Genotyping Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Genotyping Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Genotyping Market: Competitive Structure
  • Table 8: Global: Genotyping Market: Key Players